Gaurav Joshi

2.5k total citations · 1 hit paper
93 papers, 1.8k citations indexed

About

Gaurav Joshi is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Gaurav Joshi has authored 93 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 38 papers in Organic Chemistry and 10 papers in Computational Theory and Mathematics. Recurrent topics in Gaurav Joshi's work include Synthesis and biological activity (19 papers), Cancer therapeutics and mechanisms (14 papers) and Synthesis and Biological Evaluation (13 papers). Gaurav Joshi is often cited by papers focused on Synthesis and biological activity (19 papers), Cancer therapeutics and mechanisms (14 papers) and Synthesis and Biological Evaluation (13 papers). Gaurav Joshi collaborates with scholars based in India, Pakistan and United Kingdom. Gaurav Joshi's co-authors include Raj Kumar, Priyadeep Bhutani, K Prabhakar, Hemant Bhutani, Atish T. Paul, Sourav Kalra, Poduri Ramarao, Sandeep Singh, Gowraganahalli Jagadeesh and Anjana Munshi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Communications and Journal of Agricultural and Food Chemistry.

In The Last Decade

Gaurav Joshi

84 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

U.S. FDA Approved Drugs from 2015–June 2020: A Perspective

2021 566 citations Gaurav Joshi, Raj Kumar et al. profile →

Peers

Countries citing papers authored by Gaurav Joshi

Since Specialization

Citations

This map shows the geographic impact of Gaurav Joshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaurav Joshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaurav Joshi more than expected).

Fields of papers citing papers by Gaurav Joshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaurav Joshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaurav Joshi. The network helps show where Gaurav Joshi may publish in the future.

Co-authorship network of co-authors of Gaurav Joshi

This figure shows the co-authorship network connecting the top 25 collaborators of Gaurav Joshi. A scholar is included among the top collaborators of Gaurav Joshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaurav Joshi. Gaurav Joshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design and synthesis of new 1,4-naphthoquinones appended sulfenylated thiazoles as cyclooxygenase II inhibitors: Exploring the utility in the development of anticancer agents 2025 ·Bioorganic Chemistry ·Sadhna Sharma, (unknown), (unknown), (unknown), Gaurav Joshi, Snigdha Singh, Roshan Kumar, Muhammad Wahajuddin, Parvin Kumar, Devender Singh, Jayant Sindhu	3
2	Design and synthesis of new benzimidazole-hybrids as anti-microbial agents: exploring the mechanistic insights as DNA gyrase inhibitors via in silico and in vitro based studies 2025 ·Journal of Biomolecular Structure and Dynamics ·Anand Maurya, (unknown), (unknown), Gaurav Joshi, Roshan Kumar, Ragini Tilak, Alka Agarwal	0
3	An indolium inspired portable colorimetric sensor for cyanide recognition in environmental samples with smartphone integration 2025 ·RSC Advances ·KIRAN KIRAN, (unknown), Priyanka Priyanka, Anil Duhan, Rahul Kumar, Snigdha Singh, Gaurav Joshi, Parvin Kumar, Devender Singh, Muhammad Wahajuddin, Jayant Sindhu	1
4	Exploring the Insights on Exosomes and their Utility in Treating Ophthalmic Disease: Delving into the Clinical Approval and Present Trials 2024 ·Current Drug Delivery ·(unknown), (unknown), (unknown), (unknown), (unknown), Gaurav Joshi, Bhupinder Kumar	1
5	Design, synthesis, and anticancer assessment of structural analogues of (E)-1-((3,4,5-trimethoxybenzylidene)amino)-4-(3,4,5-trimethoxyphenyl)imidazo[1,2-a]quinoxaline-2-carbonitrile (6b), an imidazo[1,2-a]quinoxaline-based non-covalent EGFR inhibitor 2024 ·RSC Medicinal Chemistry ·Manvendra Kumar, (unknown), (unknown), (unknown), (unknown), Gaurav Joshi, Sandeep K. Singh, Raj Kumar	2
6	Role of autophagy and proteostasis in neurodegenerative diseases: Exploring the therapeutic interventions 2024 ·Chemical Biology & Drug Design ·Surbhi Panwar, (unknown), Neelima Kukreti, (unknown), (unknown), (unknown), Gaurav Joshi	8
7	Imidazo[1,2‐ a ]Quinoxaline‐2‐Carbonitrile Derivative (RA‐22) Inhibits Self‐Renewal and Growth of Cancer Stem and Cancer Cells via Downregulating AKT Pathway 2024 ·ChemistrySelect ·(unknown), Umesh Prasad Yadav, Gaurav Joshi, Sahil Arora, Manvendra Kumar, (unknown), Vikas Chandra, Sandeep Singh, Raj Kumar, Santosh Kumar	2
8	A decade of USFDA-approved small molecules as anti-inflammatory agents: Recent trends and Commentaries on the “industrial” perspective 2023 ·European Journal of Medicinal Chemistry ·(unknown), Ashish Ranjan Dwivedi, (unknown), Vikas Rana, (unknown), (unknown), Gaurav Joshi, Asim Kumar, Bhupinder Kumar	6
9	Precisely designed NIR based conjugated framework as a solid state emitter for selective recognition of cyanide ion in solid state and cancer cells 2023 ·Journal of Photochemistry and Photobiology A Chemistry ·KIRAN KIRAN, (unknown), (unknown), Gaurav Joshi, Roshan Kumar, Sudhir Kumar, Parvin Kumar, Snigdha Singh, Jayant Sindhu	12
10	Precisely designed oxazolonaphthoimidazo[1,2-a]pyridine-based sensor for the detection of Fe3+ and DCP with cell imaging application 2023 ·Journal of Photochemistry and Photobiology A Chemistry ·(unknown), KIRAN KIRAN, (unknown), Mayank Mayank, Gaurav Joshi, Roshan Kumar, Jayant Sindhu, Parvin Kumar, Arvind Negi, Sudhir Kumar	11
11	A review on reported phytochemicals as druggable leads with antimalarial potential 2023 ·Medicinal Chemistry Research ·(unknown), Asim Kumar, (unknown), Gaurav Joshi, Ashish Ranjan Dwivedi	2
12	Phytochemical analysis and high‐performance thin‐layer chromatography guided quantification of Boeravinone B from Boerhaavia diffusa root extracts: Assessment of in vitro safety analysis 2023 ·Separation Science Plus ·(unknown), (unknown), (unknown), Bhupinder Kumar, Poduri Ramarao, Gaurav Joshi	0
13	Machine learning techniques for prediction of osteoporosis: a comprehensive survey 2023 ·IET conference proceedings. ·(unknown), Gaurav Joshi, (unknown), (unknown), (unknown), (unknown)	1
14	Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy 2022 ·Human Vaccines & Immunotherapeutics ·Gaurav Joshi, Poduri Ramarao	12
15	Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go? 2021 ·Human Vaccines & Immunotherapeutics ·Gaurav Joshi, Pobitra Borah, Shweta Thakur, Praveen Sharma, Mayank Mayank, Poduri Ramarao	18
16	Biodegradable nanoparticulate co-delivery of flavonoid and doxorubicin: Mechanistic exploration and evaluation of anticancer effect in vitro and in vivo 2021 ·SHILAP Revista de lepidopterología ·Iliyas Khan, Bibekananda Sarkar, Gaurav Joshi, Kartik T. Nakhate, M. Ajazuddin, Anil K. Mantha, Raj Kumar, Ankur Kaul, Shubhra Chaturvedi, Anil K. Mishra, Umesh Gupta	10
17	Selection of Active Antiviral Compounds Against COVID-19 Disease Targeting Coronavirus Endoribonuclease Nendou/NSP15 Via Ligandbased Virtual Screening and Molecular Docking 2020 ·Letters in Drug Design & Discovery ·Gaurav Joshi, Poduri Ramarao	2
18	Exploration of Pd-catalysed four-component tandem reaction for one-pot assembly of pyrazolo[1,5-c]quinazolines as potential EGFR inhibitors 2019 ·Bioorganic Chemistry ·(unknown), Gaurav Joshi, Umesh Prasad Yadav, Antim K. Maurya, Vijai K. Agnihotri, Sourav Kalra, Raj Kumar, Sandeep Singh, Devesh M. Sawant	21
19	Epidermal Growth Factor Receptor (EGFR) and its Cross-Talks with Topoisomerases: Challenges and Opportunities for Multi-Target Anticancer Drugs 2016 ·Current Pharmaceutical Design ·Monika Chauhan, (unknown), Gaurav Joshi, Raj Kumar	8
20	Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents 2015 ·Chemico-Biological Interactions ·Gaurav Joshi, Pankaj Kumar Singh, Arvind Negi, (unknown), Sandeep Singh, Raj Kumar	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact